These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Validation of photoplethysmography- and acceleration-based sleep staging in a community sample: comparison with polysomnography and Actiwatch.
    Author: Liu PK, Ting N, Chiu HC, Lin YC, Liu YT, Ku BW, Lee PL.
    Journal: J Clin Sleep Med; 2023 Oct 01; 19(10):1797-1810. PubMed ID: 37338335.
    Abstract:
    STUDY OBJECTIVES: Although wrist-worn consumer wearables are widely used for home sleep monitoring, few have been validated. It is unclear whether consumer wearables could be an alternative to Actiwatch. This study aimed to establish and validate an automatic sleep staging system (ASSS) utilizing photoplethysmography and acceleration data collected from a wrist-worn wearable device. METHODS: Seventy-five participants from a community population underwent overnight polysomnography (PSG) while wearing a smartwatch (MT2511) and Actiwatch Spectrum Plus (Philips Respironics, Inc; Murrysville, PA, USA). Photoplethysmography and acceleration data collected from the smartwatches were utilized to build a 4-stage (wake, light sleep, deep sleep, and rapid eye movement [REM] sleep) classifier, which was validated against PSG. The performance of the sleep/wake classifier was compared with Actiwatch. All analyses were conducted separately for participants with PSG sleep efficiency (SE) ≥ 80% and SE < 80%. RESULTS: The 4-stage classifier and PSG showed fair overall epoch-by-epoch agreement (kappa, 0.55; 95% confidence interval, 0.52 to 0.57). The deep sleep and REM times were comparable between ASSS and PSG, while ASSS underestimated the wake time and overestimated the light sleep time among participants with SE < 80%. Moreover, ASSS underestimated sleep-onset latency and wake after sleep onset and overestimated total sleep time and SE among participants with SE < 80%, while all were comparable among participants with SE ≥ 80%. The biases were smaller for ASSS than for Actiwatch. CONCLUSIONS: Our photoplethysmography- and acceleration-based ASSS was reliable for participants with SE ≥ 80% and had a smaller bias than Actiwatch among those with SE < 80%. Thus, ASSS may be a promising alternative to Actiwatch. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; Name: Validation of Sleep Healthcare System; URL: https://clinicaltrials.gov/study/NCT04252482; Identifier: NCT04252482. CITATION: Liu P-K, Ting N, Chiu H-C, et al. Validation of photoplethysmography- and acceleration-based sleep staging in a community sample: comparison with polysomnography and Actiwatch. J Clin Sleep Med. 2023;19(10):1797-1810.
    [Abstract] [Full Text] [Related] [New Search]